litlas
Log inCreate account

Gary J. Kelloff

Active 1966–2023

97
Papers
19,466
Citations
81
h-index
97
i10-index

Citations

Citations per year for Gary J. Kelloff1966: 2 citations1967: 2 citations1968: 1 citations1969: 2 citations1970: 2 citations1971: 15 citations1972: 18 citations1973: 10 citations1974: 12 citations1975: 2 citations1976: 3 citations1977: 1 citations1978: 2 citations1979: 2 citations1980: 1 citations1982: 3 citations1983: 2 citations1984: 2 citations1986: 1 citations1990: 2 citations1991: 16 citations1992: 22 citations1993: 23 citations1994: 47 citations1995: 42 citations1996: 91 citations1997: 69 citations1998: 116 citations1999: 180 citations2000: 241 citations2001: 294 citations2002: 357 citations2003: 322 citations2004: 373 citations2005: 298 citations2006: 283 citations2007: 239 citations2008: 194 citations2009: 179 citations2010: 147 citations2011: 151 citations2012: 118 citations2013: 122 citations2014: 109 citations2015: 117 citations2016: 91 citations2017: 89 citations2018: 95 citations2019: 248 citations2020: 240 citations2021: 196 citations2022: 143 citations2023: 105 citations2024: 144 citations2025: 76 citations2026: 3 citations1981: no citations, so this year is not shown1985: no citations, so this year is not shown1987–1989: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,408 citing papers, 39% of this breakdownUnited Kingdom: 406 citing papers, 6.6% of this breakdownChina: 309 citing papers, 5% of this breakdownItaly: 267 citing papers, 4.3% of this breakdownGermany: 237 citing papers, 3.9% of this breakdownIndia: 230 citing papers, 3.7% of this breakdownJapan: 209 citing papers, 3.4% of this breakdownCanada: 204 citing papers, 3.3% of this breakdownFrance: 186 citing papers, 3% of this breakdownSouth Korea: 147 citing papers, 2.4% of this breakdownNetherlands: 144 citing papers, 2.3% of this breakdownSpain: 115 citing papers, 1.9% of this breakdown
0%39%Other 21.2%

Institutions

Fields

  • Medicine53.6%
  • Biochemistry, Genetics and Molecular Biology31.4%
  • Agricultural and Biological Sciences3.4%
  • Pharmacology, Toxicology and Pharmaceutics1.9%
  • Immunology and Microbiology1.7%
  • Chemistry1.5%
  • Other6.5%

Topics

  • Inflammatory mediators and NSAID effects5.3%
  • Genomics, phytochemicals, and oxidative stress3.1%
  • Curcumin's Biomedical Applications2.8%
  • Estrogen and related hormone effects2.8%
  • Cancer Genomics and Diagnostics1.9%
  • Cancer, Lipids, and Metabolism1.8%
  • Other82.3%

Coauthors

All papers

Open in search
  1. Association of Minimal Residual Disease With Clinical Outcome in Pediatric and Adult Acute Lymphoblastic Leukemia

    Authors: Donald A. Berry, Shouhao Zhou, Howard R. Higley, Lata Mukundan, Shuangshuang Fu, Gregory H. Reaman, Brent L. Wood, Gary J. Kelloff, J. Milburn Jessup, Jerald P. Radich - JAMA Oncology 2017 cited by 568

  2. Minimal Residual Disease in Myeloma: Application for Clinical Care and New Drug Registration

    Authors: Kenneth C. Anderson, Daniel Auclair, Stacey J. Adam, Amit Agarwal, Melissa Anderson, Hervé Avet‐Loiseau, Mark Bustoros, Jessica R. Chapman, Dana E. Connors, Ajeeta B. Dash, Alessandra Di Bacco, Du Ling, Thierry Façon, Juan Flores‐Montero, Francesca Gay, Irene M. Ghobrial, Nicole Gormley, Ira Gupta, Howard R. Higley, Jens Hillengaß, Bindu Kanapuru, Dickran Kazandjian, Gary J. Kelloff, Ilan R. Kirsch, Brandon E. Kremer, Ola Landgren, Elizabeth D. Lightbody, Oliver Lomas, Sagar Lonial, María‐Victoria Mateos, Rocío Montes de, Lata Mukundan, Nikhil C. Munshi, Elizabeth O’Donnell, Alberto Órfão, Bruno Paiva, Reshma Patel, Trevor J. Pugh, Karthik Ramasamy, Jill Ray, Mikhail Roshal, Jeremy A. Ross, Caroline C. Sigman, Katie Thoren, Suzanne Trudel, Gary A. Ulaner, Nancy Valente, Brendan M. Weiss, Elena Zamagni, Shaji Kumar - Clinical Cancer Research 2021 cited by 64

  3. Progress and Promise of FDG-PET Imaging for Cancer Patient Management and Oncologic Drug Development

    Authors: Gary J. Kelloff, John M. Hoffman, Bruce E. Johnson, Howard I. Scher, Barry A. Siegel, Edward Y. Cheng, Bruce D. Cheson, Joyce O’Shaughnessy, Kathryn Z. Guyton, David A. Mankoff, Lalitha Shankar, Steven M. Larson, Caroline C. Sigman, Richard L. Schilsky, Daniel C. Sullivan - Clinical Cancer Research 2005 cited by 669

  4. Challenges to Using Big Data in Cancer

    Authors: Shawn M. Sweeney, Hisham K. Hamadeh, Natalie Abrams, Stacey J. Adam, Sara Brenner, Dana E. Connors, Gerard J. Davis, Louis D. Fiore, Susan H. Gawel, Robert L. Grossman, Sean E. Hanlon, Karl Hsu, Gary J. Kelloff, Ilan R. Kirsch, Bill Louv, Deven McGraw, Frank Meng, Daniel Milgram, Robert S. Miller, Emily Morgan, Lata Mukundan, Thomas O’Brien, Paul B. Robbins, Eric H. Rubin, Wendy S. Rubinstein, Liz Salmi, Teilo Schaller, George Shi, Caroline C. Sigman, Sudhir Srivastava - Cancer Research 2023 cited by 60

  5. The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous Polyposis

    Authors: Gideon Steinbach, Patrick M. Lynch, Robin Phillips, Marina Wallace, Ernest T. Hawk, Gary Gordon, Naoki Wakabayashi, Brian P. Saunders, Yu Shen, Takashi Fujimura, Li-Kuo Su, Bernard Levin, LOUIS B. GODIO, Sherri Patterson, Miguel A. Rodrı́guez-Bigas, Susan L. Jester, Karen L. King, Marta Schumacher, James L. Abbruzzese, Raymond N. DuBois, Walter N. Hittelman, Stuart O. Zimmerman, Jeffrey W. Sherman, Gary J. Kelloff - New England Journal of Medicine 2000 cited by 2,526

  6. Prognostic value of interim FDG-PET in diffuse large cell lymphoma: results from the CALGB 50303 Clinical Trial

    Authors: Heiko Schöder, Mei‐Yin C. Polley, Michael V. Knopp, Nathan C. Hall, Lale Kostakoglu, Jun Zhang, Howard R. Higley, Gary J. Kelloff, Heshan Liu, Andrew D. Zelenetz, Bruce D. Cheson, Nina D. Wagner‐Johnston, Brad S. Kahl, Jonathan W. Friedberg, Eric D. Hsi, John P. Leonard, Lawrence H. Schwartz, Wyndham H. Wilson, Nancy L. Bartlett - Blood 2020 cited by 94

  7. Considerations in the development of circulating tumor cell technology for clinical use

    Authors: David Parkinson, Nicholas C. Dracopoli, Brenda Gumbs Petty, Carolyn C. Compton, Massimo Cristofanilli, Albert Deisseroth, Daniel F. Hayes, Gordon F. Kapke, Prasanna Kumar, Jerry Lee, Minetta C. Liu, Robert McCormack, Stanislaw M. Mikulski, Larry A. Nagahara, Klaus Pantel, Sonia Pearson‐White, Elizabeth A. Punnoose, Lori Roadcap, Andrew E. Schade, Howard I. Scher, Caroline C. Sigman, Gary J. Kelloff - Journal of Translational Medicine 2012 cited by 327

  8. Cancer biomarkers: selecting the right drug for the right patient

    Authors: Gary J. Kelloff, Caroline C. Sigman - Nature Reviews Drug Discovery 2012 cited by 251

  9. Lung Master Protocol (Lung-MAP)—A Biomarker-Driven Protocol for Accelerating Development of Therapies for Squamous Cell Lung Cancer: SWOG S1400

    Authors: Roy S. Herbst, David R. Gandara, Fred R. Hirsch, Mary W. Redman, Michael LeBlanc, Philip C. Mack, Lawrence H. Schwartz, Everett E. Vokes, Suresh S. Ramalingam, Jeffrey D. Bradley, Dana B. Sparks, Yang Zhou, Crystal Miwa, Vincent A. Miller, Roman Yelensky, Yali Li, Jeff Allen, Ellen V. Sigal, David Wholley, Caroline C. Sigman, Gideon M. Blumenthal, Shakun Malik, Gary J. Kelloff, Jeffrey S. Abrams, Charles D. Blanke, Vassiliki A. Papadimitrakopoulou - Clinical Cancer Research 2015 cited by 240

  10. Case Studies for Overcoming Challenges in Using Big Data in Cancer

    Authors: Shawn M. Sweeney, Hisham K. Hamadeh, Natalie Abrams, Stacey J. Adam, Sara Brenner, Dana E. Connors, Gerard J. Davis, Louis D. Fiore, Susan H. Gawel, Robert L. Grossman, Sean E. Hanlon, Karl Hsu, Gary J. Kelloff, Ilan R. Kirsch, Bill Louv, Deven McGraw, Frank Meng, Daniel Milgram, Robert S. Miller, Emily Morgan, Lata Mukundan, Thomas O’Brien, Paul B. Robbins, Eric H. Rubin, Wendy S. Rubinstein, Liz Salmi, Teilo Schaller, George Shi, Caroline C. Sigman, Sudhir Srivastava - Cancer Research 2023 cited by 21

  11. Difluoromethylornithine Plus Sulindac for the Prevention of Sporadic Colorectal Adenomas: A Randomized Placebo-Controlled, Double-Blind Trial

    Authors: Frank L. Meyskens, Christine E. McLaren, Daniel Pelot, Sharon Fujikawa-Brooks, Philip M. Carpenter, Ernest T. Hawk, Gary J. Kelloff, Michael J. Lawson, Jayashri Kidao, John A. McCracken, Gregory Albers, Dennis J. Ahnen, D. Kim Turgeon, Steven Goldschmid, Peter Lance, Curt H. Hagedorn, Daniel L. Gillen, Eugene W. Gerner - Cancer Prevention Research 2008 cited by 519

  12. State of the Science and Future Directions for Liquid Biopsies in Drug Development

    Authors: Preeti Narayan, Soma Ghosh, Reena Philip, J. Carl Barrett, Robert McCormack, Justin I. Odegaard, Geoffrey R. Oxnard, Laurel J. Pracht, P. Mickey Williams, Gary J. Kelloff, Julia A. Beaver - The Oncologist 2020 cited by 15

  13. The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis.

    Authors: Russell F. Jacoby, Karen Seibert, Carolyn E. Cole, Gary J. Kelloff, Ronald A. Lubet - 2000 cited by 483

  14. The Role of Minimal Residual Disease Testing in Myeloma Treatment Selection and Drug Development: Current Value and Future Applications

    Authors: Kenneth C. Anderson, Daniel Auclair, Gary J. Kelloff, Caroline C. Sigman, Hervé Avet‐Loiseau, Ann T. Farrell, Nicole Gormley, Shaji Kumar, Ola Landgren, Nikhil C. Munshi, Michèle Cavo, Faith E. Davies, Alessandra Di Bacco, Jennifer S. Dickey, Steven Gutman, Howard R. Higley, Mohamad A. Hussein, J. Milburn Jessup, Ilan R. Kirsch, Richard F. Little, Robert D. Loberg, Jens G. Lohr, Lata Mukundan, James Omel, Trevor J. Pugh, Gregory H. Reaman, Michael Robbins, A. Kate Sasser, Nancy Valente, Elena Zamagni - Clinical Cancer Research 2017 cited by 91

  15. Evidence of Clinical Utility: An Unmet Need in Molecular Diagnostics for Patients with Cancer

    Authors: David Parkinson, Robert McCormack, Susan M. Keating, Steven Gutman, Stanley R. Hamilton, Elizabeth Mansfield, Margaret Piper, Patricia A. Deverka, Felix W. Frueh, J. Milburn Jessup, Lisa M. McShane, Sean Tunis, Caroline C. Sigman, Gary J. Kelloff - Clinical Cancer Research 2014 cited by 91

  16. Progress in Cancer Chemoprevention: Development of Diet-Derived Chemopreventive Agents

    Authors: Gary J. Kelloff, James A. Crowell, Vernon E. Steele, Ronald A. Lubet, Winfred A. Malone, Charles W. Boone, Levy Kopelovich, Ernest T. Hawk, Ronald Lieberman, Julia Lawrence, Imran Ali, Jaye L. Viner, Caroline C. Sigman - Journal of Nutrition 2000 cited by 443

  17. Chemoprevention of colon carcinogenesis by organosulfur compounds.

    Authors: B. Seetharami Reddy, Chinthalapally V. Rao, Abraham Rivenson, Gary J. Kelloff - 1993 cited by 226

  18. Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer.

    Authors: Toshihiko Kawamori, R Lubet, Vernon E. Steele, Gary J. Kelloff, Robert B. Kaskey, Chinthalapally V. Rao, B. Seetharami Reddy - 1999 cited by 592

  19. Efficacy of potential chemopreventive agents on rat colon aberrant crypt formation and progression

    Authors: Michael J. Wargovich, Arnaldo Jimenez, Kathy McKee, Vernon E. Steele, Marco A. De Velasco, Johnnie Woods, Roger E. Price, Kenneth N. Gray, Gary J. Kelloff - Carcinogenesis 2000 cited by 258

  20. Retinoids in chemoprevention and differentiation therapy

    Authors: Laura A. Hansen, Caroline C. Sigman, Fausto Andreola, Sharon A. Ross, Gary J. Kelloff, Luigi M. De Luca - Carcinogenesis 2000 cited by 243

  21. Strategy and planning for chemopreventive drug development: Clinical development plans II

    Authors: Gary J. Kelloff, James A. Crowell, Ernest T. Hawk, Vernon E. Steele, Ronald A. Lubet, Charles W. Boone, Joseph M. Covey, Linda A. Doody, Gilbert S. Omenn, Peter Greenwald, W K Hong, David Parkinson, Donya Bagheri, Gregory T. Baxter, Margaret Blunden, Mary K. Doeltz, Karen Eisenhauer, Karen M. Johnson, Gene Knapp, David G. Longfellow, Winfred F. Malone, Susan Nayfield, Harold E. Seifried, Leah M. Swall, Caroline C. Sigman - Journal of Cellular Biochemistry 1996 cited by 194

  22. Challenges in Clinical Prostate Cancer: Role of Imaging

    Authors: Gary J. Kelloff, Peter L. Choyke, Donald S. Coffey - American Journal of Roentgenology 2009 cited by 183

  23. New science-based endpoints to accelerate oncology drug development

    Authors: Gary J. Kelloff, Caroline C. Sigman - European Journal of Cancer 2005 cited by 93

  24. Chemoprevention of rat prostate carcinogenesis by early and delayed administration of dehydroepiandrosterone.

    Authors: K. V. N. Rao, William D. Johnson, Maarten C. Bosland, Ronald A. Lubet, Vernon E. Steele, Gary J. Kelloff, David L. McCormick - 1999 cited by 78